Psychedelics, Depression, and the Brain: A Breakthrough Framework for Mental Health

In this episode of The Dr. Hyman Show, Dr. Mark Hyman interviews Dr. Robin Carhart-Harris, a neuroscientist and leading researcher in psychedelic therapy, about the use of psychedelic medicines in treating mental health conditions. They discuss Carhart-Harris's journey into the field, the mechanistic understanding of how psychedelics impact the brain, and the potential for these compounds to revolutionize psychiatry. Carhart-Harris explains his entropic brain principle, which describes how psychedelics increase entropy and flexibility in brain function, allowing individuals to break free from rigid patterns of thinking and feeling. They explore the clinical applications of various psychedelic compounds, the importance of set and setting in psychedelic-assisted therapy, and the potential risks and concerns associated with their use. The conversation also touches on the future of psychedelic research, including the use of AI to personalize therapy and the possibility of psilocybin therapy becoming a licensed medicine for depression.